APD
52
-2
HAL
57
6
AKAM
56
-3
VNO
49
8
PG
53
-2
WY
39
2
MDT
60
-3
CPB
39
2
DLTR
66
4
DTE
38
-4
SO
53
-4
TGNA
48
-2
PYPL
52
3
BBY
50
9
FITB
73
-2
SE
47
-2
VIX
35
-5
BAX
44
2
TRIP
60
2
FIS
56
3
APD
52
-2
HAL
57
6
AKAM
56
-3
VNO
49
8
PG
53
-2
WY
39
2
MDT
60
-3
CPB
39
2
DLTR
66
4
DTE
38
-4
SO
53
-4
TGNA
48
-2
PYPL
52
3
BBY
50
9
FITB
73
-2
SE
47
-2
VIX
35
-5
BAX
44
2
TRIP
60
2
FIS
56
3
Financhill
Back

Apogee Therapeutics, Inc. 10K Form

Buy
77

APGE
Apogee Therapeutics, Inc.

Last Price:
$76.85
Seasonality Move:
39.09%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive APGE News And Ratings

See the #1 stock for the next 7 days that we like better than APGE

APGE Financial Statistics

Sales & Book Value

Annual Sales: $0
Cash Flow: $-54.3M
Price / Cash Flow: 0
Annual Sales: $8.05
Price / Book: 8.94

Profitability

EPS (TTM): -4.31850
Net Income (TTM): $-253.7M
Gross Margin: $-189K
Return on Equity: -38.09%
Return on Assets: -35.95%

Apogee Therapeutics, Inc. Earnings Forecast

Key Apogee Therapeutics, Inc. Financial Ratios

  • Per Share Earnings over the last 3 years have been positive in 0 years.

Apogee Therapeutics, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: APGE
Website: apogeetherapeutics.com

Debt

Debt-to-Equity Ratio: 0.02
Current Ratio: 15.86
Quick Ratio: 15.49

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

APGE Technical Analysis vs Fundamental Analysis

Buy
77
Apogee Therapeutics, Inc. (APGE) is a Buy

Is Apogee Therapeutics, Inc. a Buy or a Sell?